Page 62 - _NIPER-G Annual Report 2019-201

Department of Pharmaceutical Analysis

The Department of Pharmaceutical Analysis was started in 2018 with M.S. Pharm and PhD to
promote quality education exposure in the area of Quality Control and Quality Assurance. The
Department of Pharmaceutical analysis aims to focus on the development of analytical
methods using new combinations of established instrumentation and approaches. It involves
basic research in identity, purity, content and stability of starting materials, excipients and
active pharmaceutical ingredients (API). The department is involved in teaching and training
post graduate students, in the subjects of analytical sciences pertaining to qualitative and
quantitative estimation of natural and synthetic compounds in various matrices by application
of spectroscopy, chromatography and analytical methods.

Major Thrust Area of the Department

 Metabolomics and lipidomic profiling of various cancer, cardiovascular and metabolic
disorder to obtain biochemical insights into disease progression and to develop non-
invasive metabolite signatures for prognostic and predictive biomarkers using non-
invasive biofluids such as urine
 Plant metabolomics study
 Analytical and bioanalytical method development and validation
 Pharmacokinetic studies of drugs and metabolites
 Identification and characterization of impurities in drug substances
 Forced degradation studies and characterization of degradation products
 Short-term/accelerated, mid-term and long-term stability testing of formulations

NIPER-G 59